An operational perturbation proteomics-based virtual cell model
- 9 September 2026
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 658 (8137) , 1066-1076
Abstract
Artificial intelligence-empowered virtual cell models represent an emerging approach for in silico drug discovery1,2,3, yet most existing approaches lack large-scale, time-resolved perturbation proteomics data and interpretable frameworks for predicting therapeutic responses. Here we generated more than 38 million temporal protein-abundance measurements from systematically perturbed breast cancer cell lines, and developed ProteinTalks, a virtual cell model. Central to ProteinTalks is the synergy of this large-scale dynamic proteomic resource and the model architecture, enabling a new pretraining framework that learns transferable dynamical latent representations from temporal proteome trajectories. By modelling how proteins respond conditionally to different perturbations, this approach enables the model to function as an operational tool for diverse drug discovery tasks: predicting drug efficacy and synergy, discovering new drug combinations, probing proteins associated with drug resistance, stratifying patient responses and prioritizing drug candidates for patient organoids. It also shows robust transferability, extending beyond cell lines to patient-derived organoids and clinical biopsies, generally achieving higher performance than the selected benchmark implementations under the evaluated protocols. Together, ProteinTalks shows how scalable pretraining of transferable dynamic representations enables operational, dynamics-aware, proteomics-based virtual cell models to advance in silico drug discovery.Keywords
This publication has 57 references indexed in Scilit:
- How to build the virtual cell with artificial intelligence: Priorities and opportunitiesCell, 2024
- AI-empowered perturbation proteomics for complex biological systemsCell Genomics, 2024
- Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein TargetsMolecular & Cellular Proteomics, 2023
- A prostate cancer tissue specific spectral library for targeted proteomic analysisProteomics, 2021
- High-throughput proteomics and AI for cancer biomarker discoveryAdvanced Drug Delivery Reviews, 2021
- Accelerated Protein Biomarker Discovery from FFPE Tissue Samples Using Single-Shot, Short Gradient Microflow SWATH MSJournal of Proteome Research, 2020
- LncRNA NEAT1 promotes autophagy via regulating miR‐204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinomaJournal of Cellular Physiology, 2019
- The LIS1/NDE1 Complex Is Essential for FGF Signaling by Regulating FGF Receptor Intracellular TraffickingCell Reports, 2018
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer CompoundsCell, 2016